Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

11
results for

"Angiogenesis"

Article category

Keywords

Publication year

"Angiogenesis"

Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Alcohol-related liver disease

The lymphatic system in alcohol-associated liver disease
Reiichiro Kondo, Yasuko Iwakiri
Clin Mol Hepatol 2020;26(4):633-638.
Published online September 21, 2020
DOI: https://doi.org/10.3350/cmh.2020.0179
The lymphatic system plays vital roles in interstitial fluid balance and immune cell surveillance. The effect of alcohol on the lymphatic system is poorly understood. This review article explores the role of the lymphatic system in the pathogenesis of alcohol-related disease including alcoholic liver disease (ALD) and the therapeutic potential of targeting hepatic lymphatics for the treatment of ALD.

Citations

Citations to this article as recorded by  Crossref logo
  • Hepatic Lymphatic System and Its Current Understanding in Liver-Related Pathophysiology
    Jingjing Pang, Jianan Zhao, Liam Flynn, Juncheng Wei, Long Nguyen Hoang Do, Esteban Delgado, Xiaolei Liu
    Lymphatics.2026; 4(1): 5.     CrossRef
  • Lymphatic system in the liver: a new frontier in liver physiology and oncology
    Reiichiro Kondo, Rio Sonoda, Jun Akiba
    Medical Molecular Morphology.2026;[Epub]     CrossRef
  • Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells
    Enis Kostallari, Robert F. Schwabe, Adrien Guillot
    Cellular & Molecular Immunology.2025; 22(10): 1205.     CrossRef
  • Characterization of prokineticin system in Crohn's disease pathophysiology and pain, and its modulation by alcohol abuse: A preclinical study
    Giada Amodeo, Giulia Galimberti, Paola Sacerdote, Silvia Franchi
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2023; 1869(7): 166791.     CrossRef
  • Endotheliopathy of liver sinusoidal endothelial cells in liver disease
    Reiichiro Kondo, Yasuko Iwakiri, Masayoshi Kage, Hirohisa Yano
    Pathology International.2023; 73(9): 381.     CrossRef
  • Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma
    Massimiliano Cadamuro, Adriana Romanzi, Maria Guido, Samantha Sarcognato, Umberto Cillo, Enrico Gringeri, Giacomo Zanus, Mario Strazzabosco, Paolo Simioni, Erica Villa, Luca Fabris
    Journal of Personalized Medicine.2022; 12(7): 1086.     CrossRef
  • 17,678 View
  • 174 Download
  • 5 Web of Science
  • Crossref

Review

Liver fibrosis, cirrhosis, and portal hypertension

The lymphatic vascular system in liver diseases: its role in ascites formation
Chuhan Chung, Yasuko Iwakiri
Clin Mol Hepatol 2013;19(2):99-104.
Published online June 27, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.2.99

The lymphatic system is part of the circulatory system and plays a key role in normal vascular function. Its failure plays a crucial role in the development and maintenance of various diseases including liver diseases. Lymphangiogenesis (the growth of lymphatic vessels) and changes in the properties of lymphatic vessels are associated with pathogenesis of tumor metastases, ascites formation, liver fibrosis/cirrhosis and portal hypertension. Despite its significant role in liver diseases and its importance as a potential therapeutic target for those diseases, the lymphatic vascular system of the liver is poorly understood. Therefore, how the lymphatic vascular system in general and lymphangiogenesis in particular are mechanistically related to the pathogenesis and maintenance of liver diseases are largely unknown. This article summarizes: 1) the lymphatic vascular system; 2) its role in liver tumors, liver fibrosis/cirrhosis and portal hypertension; and 3) its role in ascites formation.

Citations

Citations to this article as recorded by  Crossref logo
  • Intrahepatic Lymphedema Presenting With Abnormal Bilirubin Metabolism as the Initial Manifestation
    Jingyao Li, Xiangyun Li, Jing Hao
    ACG Case Reports Journal.2026;[Epub]     CrossRef
  • Hepatic Lymphatic System and Its Current Understanding in Liver-Related Pathophysiology
    Jingjing Pang, Jianan Zhao, Liam Flynn, Juncheng Wei, Long Nguyen Hoang Do, Esteban Delgado, Xiaolei Liu
    Lymphatics.2026; 4(1): 5.     CrossRef
  • Long-Term Care in Fontan Circulation: Surveillance and Management of Fontan-Associated Liver Disease and Protein-Losing Enteropathy
    Chaowapong Jarasvaraparn, Gary R. Schooler, Iván A. González, Salil Ginde, Alisha Mavis
    Current Cardiology Reports.2026;[Epub]     CrossRef
  • Development and Validation of a Nomogram Predictive Model for Massive Ascites After Hepatectomy in Patients with Primary Hepatocellular Carcinoma
    Ao Men, Dapeng Sun, Xiuqing Sun, Luyuan Jin, Bailiang Liu, Fengyang Chen, Boyuan Nan, Wenxin Wang, Lei Han, Wei Zhang
    Journal of Hepatocellular Carcinoma.2026; Volume 13: 1.     CrossRef
  • Lymphatic system in the liver: a new frontier in liver physiology and oncology
    Reiichiro Kondo, Rio Sonoda, Jun Akiba
    Medical Molecular Morphology.2026;[Epub]     CrossRef
  • Immunocytochemical staining for lymphatic and blood vessels with frozen sections: using LYVE-1 for lymphatic vessel and von Willebrand factor for blood vessel marker
    Tatsuo Tomita, Kunie Mah
    European Journal of Histochemistry.2026;[Epub]     CrossRef
  • Cisterna Chyli Dilation Is a Risk Factor for Liver Nodules and Hepatocellular Carcinoma in Fontan‐Associated Liver Disease: Pathophysiological Role of Lymphatic Dysfunction
    Koji Imoto, Masatake Tanaka, Takeshi Goya, Yuuki Azuma, Tomonobu Hioki, Yusuke Morita, Keisuke Sakaguchi, Nobuhiro Fujita, Takamori Kakino, Ayako Ishikita, Kenichiro Yamamura, Ichiro Sakamoto, Kousei Ishigami, Kohtaro Abe, Yoshihiro Ogawa
    Hepatology Research.2026;[Epub]     CrossRef
  • Impact of nanoparticle properties on immune cell interactions in the lymph node
    Muhammad Asim Farooq, Angus P.R. Johnston, Natalie L. Trevaskis
    Acta Biomaterialia.2025; 193: 65.     CrossRef
  • Unveiling the Systemic Impact of Congestion in Heart Failure: A Narrative Review of Multisystem Pathophysiology and Clinical Implications
    Daniela Mocan, Radu Jipa, Daniel Alexandru Jipa, Radu Ioan Lala, Florin Claudiu Rasinar, Iulia Groza, Ronela Sabau, Damaris Sulea Bratu, Diana Federica Balta, Sergiu Teodor Cioban, Maria Puschita
    Journal of Cardiovascular Development and Disease.2025; 12(4): 124.     CrossRef
  • Peripheral vs. central parametric mapping of the liver in single ventricle patients: Measurement location matters
    Anna Yanovskiy, Tiina Ojala, Alma Kormi, Reetta Kivisaari, Juha Peltonen, Laura Martelius
    European Journal of Radiology.2025; 188: 112158.     CrossRef
  • The interplay between lymphatic system and portal hypertension: a comprehensive review
    Pinky Juneja, Rajni Yadav, Dinesh M. Tripathi, Savneet Kaur
    Hepatology International.2025; 19(4): 720.     CrossRef
  • Ascites – the Old, the Current, and the Future Ways of Management
    Christine Pocha, Cristian Rios-Perez
    Current Hepatology Reports.2025;[Epub]     CrossRef
  • Portal hypertension contributes to ascites formation via the Piezo1−nuclear factor kappa-B−aquaporin1 pathway in liver cirrhosis
    Ning Wei, Li Du, Zhuanglong Xiao, Lei Zhang, Yangyang Zhou, Haonan Gao, Minghui Liu, Chengbo Wang, Xiaohua Hou, Yan Li, Yuhu Song
    Experimental & Molecular Medicine.2025; 57(10): 2305.     CrossRef
  • Risk stratification of spontaneous bacterial peritonitis recurrence: integrating acute kidney injury, biomarkers, composite scores, and machine learning models
    Nasser Mousa, Alaa Elmetwalli, Mostafa Abdelsalam, Mohamed Wahba, Mohamed Selim, Dina Nour, Eman Abdelkader, Ahmed El-Eraky, Amany Hasson, Ahmed E Taha, Eman Mousa, Adel El-Assmy, Ali El-Assmy, Sherif Shiha, Muhammad Diasty, Mohammed Abdelaziz, Shereen A.
    Gut Pathogens.2025;[Epub]     CrossRef
  • Deep brain lymphatic vessels: a new player in brain functions, neurodegenerative diseases and psychiatric disorders
    Bingqing Guo, Junzhuang Chang, Nashat Abumaria
    Stress and Brain.2024; 4(1): 46.     CrossRef
  • Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension
    Frane Pastrovic, Rudjer Novak, Ivica Grgurevic, Stela Hrkac, Grgur Salai, Marko Zarak, Lovorka Grgurevic, Sona Frankova
    PLOS ONE.2024; 19(4): e0301416.     CrossRef
  • Lymphedema in a patient with decompensated cirrhosis
    Elanaz Alizade, Muhsin Murat Harputluoğlu, Ali Alizade
    Annals of Innovation in Medicine.2024;[Epub]     CrossRef
  • Single-Center Experience With Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography for Diagnosing Lymphatic Disorders and Guiding Percutaneous Embolization
    Yura Ahn, Hyun Jung Koo, Jooae Choe, Hee Ho Chu, Dong Hyun Yang, Joon-Won Kang, Ji Hoon Shin
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Lymphatic System Development and Function
    Harish P. Janardhan, Brianna T. Wachter, Chinmay M. Trivedi
    Current Cardiology Reports.2024; 26(11): 1209.     CrossRef
  • Lymphangiogenesis in the liver of biliary atresia
    Seitaro Kosaka, Toshihiro Muraji, Haruo Ohtani, Toshio Harumatsu, Sakika Shimizu, Miki Toma, Toshihiro Yanai, Satoshi Ieiri
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • The ebb and flow of cardiac lymphatics: a tidal wave of new discoveries
    Natalie R. Harris, László Bálint, Danielle M. Dy, Natalie R. Nielsen, Hernán G. Méndez, Amir Aghajanian, Kathleen M. Caron
    Physiological Reviews.2023; 103(1): 391.     CrossRef
  • Clinical anatomy of hepatic vessels by computed tomography angiography: A minireview
    Aysegul Firat, Tugce Taskindere Abbasoglu, Musturay Karcaaltincaba, Yasemin H Balaban
    World Journal of Radiology.2023; 15(1): 1.     CrossRef
  • Fontan-associated liver disease: Diagnosis, surveillance, and management
    Charlotte de Lange, Thomas Möller, Hanna Hebelka
    Frontiers in Pediatrics.2023;[Epub]     CrossRef
  • Lymphatics in the liver for translational science
    Yasuko Iwakiri
    Clinical Liver Disease.2023; 21(4): 122.     CrossRef
  • Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis
    Pinky Juneja, Syed Nazrin Ruhina Rahman, Deepika Jakhar, Akash Kumar Mourya, Dinesh M. Tripathi, Impreet Kaur, Vaibhav Tiwari, Sumati Rohilla, Abhishek Gupta, Preety Rawal, Sukriti Baweja, Archana Rastogi, V.G.M. Naidu, Shiv K. Sarin, Subham Banerjee, Sav
    JHEP Reports.2023; 5(10): 100816.     CrossRef
  • Lymphatic vasculature in ovarian cancer
    Sarit Pal, Sramana Bhowmick, Anurag Sharma, Jorge A. Sierra-Fonseca, Susmita Mondal, Favour Afolabi, Debarshi Roy
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2023; 1878(5): 188950.     CrossRef
  • Oxidative Stress–Induced Liver Damage and Remodeling of the Liver Vasculature
    Priyanka Banerjee, Niyanshi Gaddam, Vanessa Chandler, Sanjukta Chakraborty
    The American Journal of Pathology.2023; 193(10): 1400.     CrossRef
  • Lymphatic drainage dysfunction via narrowing of the lumen of cisterna chyli and thoracic duct after luminal dilation
    Ryo Yano, Masashi Hirooka, Yohei Koizumi, Yoshiko Nakamura, Yusuke Imai, Makoto Morita, Yuki Okazaki, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa
    Hepatology International.2023; 17(6): 1557.     CrossRef
  • An optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liver
    Jain Jeong, Masatake Tanaka, Yilin Yang, Nikolai Arefyev, Jenna DiRito, Gregory Tietjen, Xuchen Zhang, Matthew J. McConnell, Teruo Utsumi, Yasuko Iwakiri
    American Journal of Physiology-Gastrointestinal and Liver Physiology.2023; 325(5): G379.     CrossRef
  • Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism
    Rahul Arya, Ramesh Kumar, Tarun Kumar, Sudhir Kumar, Utpal Anand, Rajeev Nayan Priyadarshi, Tanmoy Maji
    World Journal of Hepatology.2023; 15(10): 1140.     CrossRef
  • Hepatic lymphatic vascular system in health and disease
    Jain Jeong, Masatake Tanaka, Yasuko Iwakiri
    Journal of Hepatology.2022; 77(1): 206.     CrossRef
  • A classification of abdominal lymphatic perfusion patterns after Fontan surgery
    Christian Schroeder, Julia Moosmann, Robert Cesnjevar, Ariawan Purbojo, Oliver Rompel, Sven Dittrich
    European Journal of Cardio-Thoracic Surgery.2022;[Epub]     CrossRef
  • Serial T2-Weighted Thoracic and Abdominal Lymphatic Imaging in Fontan Patients—New Insights into Dynamics of Lymphatic Abnormalities after Total Cavopulmonary Connection
    Julia Moosmann, Christian Schroeder, Oliver Rompel, Ariawan Purbojo, Sven Dittrich
    Journal of Cardiovascular Development and Disease.2022; 9(5): 138.     CrossRef
  • Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites
    Masashi Hirooka, Yohei Koizumi, Ryo Yano, Yoshiko Nakamura, Koutarou Sunago, Atsushi Yukimoto, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa
    Scientific Reports.2022;[Epub]     CrossRef
  • A Metabolomic Analysis of Cirrhotic Ascites
    Diren Beyoğlu, Cedric Simillion, Federico Storni, Andrea De Gottardi, Jeffrey R. Idle
    Molecules.2022; 27(12): 3935.     CrossRef
  • Paneth Cells Regulate Lymphangiogenesis under Control of Microbial Signals during Experimental Portal Hypertension
    Mohsin Hassan, Oriol Juanola, Irene Keller, Paolo Nanni, Witold Wolski, Sebastián Martínez-López, Esther Caparrós, Rubén Francés, Sheida Moghadamrad
    Biomedicines.2022; 10(7): 1503.     CrossRef
  • Oxidized low density lipoprotein in the liver causes decreased permeability of liver lymphatic- but not liver sinusoidal-endothelial cells via VEGFR-3 regulation of VE-Cadherin
    Alyssa R. Goldberg, Megan Ferguson, Sarit Pal, Rachel Cohen, David J. Orlicky, Rebecca L. McCullough, Joseph M. Rutkowski, Matthew A. Burchill, Beth A. Jirón Tamburini
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Abdominal lymphatic system visibility, morphology, and abnormalities in children as seen on routine MCRP and its association with immune-mediated diseases
    Ebtehaj AlShehri, Christopher Z. Lam, Binita M. Kamath, Govind B. Chavhan
    European Radiology.2021; 31(1): 292.     CrossRef
  • Potential of Liver T1 Mapping for the Detection of Fontan-associated Liver Disease in Adults
    Yumi Shiina, Kei Inai, Ryoko Ohashi, Michinobu Nagao
    Magnetic Resonance in Medical Sciences.2021; 20(3): 295.     CrossRef
  • Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice
    Kyung-A Byun, Seyeon Oh, Myeongjoo Son, Chul-Hyun Park, Kuk Hui Son, Kyunghee Byun
    Marine Drugs.2021; 19(9): 495.     CrossRef
  • Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications
    Ramesh Kumar, Utpal Anand, Rajeev Nayan Priyadarshi
    World Journal of Hepatology.2021; 13(3): 300.     CrossRef
  • Pathophysiology of the Lymphatic System in Patients With Heart Failure
    Maxim Itkin, Stanley G. Rockson, Daniel Burkhoff
    Journal of the American College of Cardiology.2021; 78(3): 278.     CrossRef
  • The Relationship Between Lymphangiogenesis and Liver Regeneration After Partial Hepatectomy in Cholestatic Mice
    Takashi Hamada, Masaaki Hidaka, Mitsuhisa Takatsuki, Yusuke Sakai, Haung Yu, Koji Natsuda, Shinichiro Ono, Tomohiko Adachi, Akihiko Soyama, Susumu Eguchi
    Lymphatic Research and Biology.2020; 18(4): 322.     CrossRef
  • The Role of Lymphatic Vascular Function in Metabolic Disorders
    Pieter R. Norden, Tsutomu Kume
    Frontiers in Physiology.2020;[Epub]     CrossRef
  • Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
    Mohammad Abdallah, Olivia O. Müllertz, Ian K. Styles, Alexander Mörsdorf, John F. Quinn, Michael R. Whittaker, Natalie L. Trevaskis
    Journal of Controlled Release.2020; 327: 117.     CrossRef
  • The lymphatic system in alcohol-associated liver disease
    Reiichiro Kondo, Yasuko Iwakiri
    Clinical and Molecular Hepatology.2020; 26(4): 633.     CrossRef
  • Liver lymphatic drainage patterns follow segmental anatomy in a murine model
    Nicola C. Frenkel, Susanna Poghosyan, André Verheem, Timothy P. Padera, Inne H. M. Borel Rinkes, Onno Kranenburg, Jeroen Hagendoorn
    Scientific Reports.2020;[Epub]     CrossRef
  • Imaging the Lymphatic System in Fontan Patients
    Floris E.A. Udink ten Cate, Eric T.T.L. Tjwa
    Circulation: Cardiovascular Imaging.2019;[Epub]     CrossRef
  • Non-contrast MR lymphography of the lymphatic system of the liver
    Lionel Arrivé, Laurence Monnier-Cholley, Nora Cazzagon, Dominique Wendum, Edouard Chambenois, Sanaâ El Mouhadi
    European Radiology.2019; 29(11): 5879.     CrossRef
  • Fontan-associated liver disease: A review
    Timothy T. Gordon-Walker, Kevin Bove, Gruschen Veldtman
    Journal of Cardiology.2019; 74(3): 223.     CrossRef
  • Chronic Liver Disease in Humans Causes Expansion and Differentiation of Liver Lymphatic Endothelial Cells
    Beth A. Jiron Tamburini, Jeffrey M. Finlon, Austin E. Gillen, Michael S. Kriss, Kent A. Riemondy, Rui Fu, Ronald P. Schuyler, Jay R. Hesselberth, Hugo R. Rosen, Matthew A. Burchill
    Frontiers in Immunology.2019;[Epub]     CrossRef
  • The Role of Hepatic and Splanchnic Lymphatic System in Portal Hypertension and Ascites
    Jordi Ribera, Bernat Córdoba-Jover, Irene Portolés, Manuel Morales-Ruiz
    Current Hepatology Reports.2019; 18(2): 157.     CrossRef
  • Nanoparticles' interactions with vasculature in diseases
    Jie Kai Tee, Li Xian Yip, Eveline Sheau Tan, Supawan Santitewagun, Arun Prasath, Pu Chun Ke, Han Kiat Ho, David Tai Leong
    Chemical Society Reviews.2019; 48(21): 5381.     CrossRef
  • Metabolism in Acute-On-Chronic Liver Failure: The Solution More than the Problem
    Maria-Angeles Aller, Natalia Arias, Javier Blanco-Rivero, Jaime Arias
    Archives of Medical Research.2019; 50(5): 271.     CrossRef
  • Gut Lymphangiopathy: Adding Fuel to the Fire in Chronic Liver Disease
    Luis Tresierra, Maria-Angeles Aller, Isabel Prieto, Luis Santamaria, Jaime Arias
    Advances in Bioscience and Biotechnology.2019; 10(10): 305.     CrossRef
  • Biology of portal hypertension
    Matthew McConnell, Yasuko Iwakiri
    Hepatology International.2018; 12(S1): 11.     CrossRef
  • Modern Techniques of Lymphangiography and Interventions: Current Status and Future Development
    Maxim Itkin, Gregory J. Nadolski
    CardioVascular and Interventional Radiology.2018; 41(3): 366.     CrossRef
  • Emerging Concepts in Organ-Specific Lymphatic Vessels and Metabolic Regulation of Lymphatic Development
    Brian W. Wong, Annalisa Zecchin, Melissa García-Caballero, Peter Carmeliet
    Developmental Cell.2018; 45(3): 289.     CrossRef
  • Lymphatics in the liver
    Masatake Tanaka, Yasuko Iwakiri
    Current Opinion in Immunology.2018; 53: 137.     CrossRef
  • Risk Factors for Intractable Ascites After Adult-to-Adult Living Donor Liver Transplantation Using Left Lobe
    Shinichi Matsudaira, Yoichi Ishizaki, Jiro Yoshimoto, Noriko Fujiwara, Seiji Kawasaki
    Transplantation Direct.2017; 3(3): e138.     CrossRef
  • Lymphangiogenesis is a feature of acute GVHD, and VEGFR-3 inhibition protects against experimental GVHD
    Sarah Mertlitz, Yu Shi, Martina Kalupa, Carsten Grötzinger, Jörg Mengwasser, Katarina Riesner, Steffen Cordes, Sefer Elezkurtaj, Olaf Penack
    Blood.2017; 129(13): 1865.     CrossRef
  • Periportal lymphatic system on post-hepatobiliary phase Gd-EOB-DTPA-enhanced MR imaging in normal subjects and patients with chronic hepatitis C
    Yasunari Yamada, Shunro Matsumoto, Hiromu Mori, Ryo Takaji, Maki Kiyonaga, Naoki Hijiya, Rika Tanoue, Kenichiro Tomonari, Shuichi Tanoue, Norio Hongo, Masayuki Ohta, Masataka Seike, Masafumi Inomata, Kazunari Murakami, Masatsugu Moriyama
    Abdominal Radiology.2017; 42(10): 2410.     CrossRef
  • MR lymphography of hepatic lymphatic system
    Lionel Arrivé, Sanaâ El Mouhadi
    Hepatology.2017; 65(6): 2132.     CrossRef
  • Reply
    Yasuko Iwakiri
    Hepatology.2017; 65(6): 2134.     CrossRef
  • The Lymphatic System: The Achilles Heel of the Fontan-Kreutzer Circulation
    Christian Kreutzer, Guillermo Kreutzer
    World Journal for Pediatric and Congenital Heart Surgery.2017; 8(5): 613.     CrossRef
  • Anti-angiogenic and anti-lymphangiogenic role of praziquantel and artemether in experimental mansoniasis
    Naglaa Fathy Abd El-Aal, Rania Said Hamza, Mona Magdy
    Acta Parasitologica.2017;[Epub]     CrossRef
  • Detection of Autoantibodies to Vascular Endothelial Growth Factor Receptor-3 in Bile Duct Ligated Rats and Correlations with a Panel of Traditional Markers of Liver Diseases
    Florent Duval, Delia Elva Cruz-Vega, Ivonne González-Gamboa, María Teresa González-Garza, Fernando Ponz, Flora Sánchez, Gabriela Alarcón-Galván, Jorge E. Moreno-Cuevas
    Disease Markers.2016; 2016: 1.     CrossRef
  • Functional Immune Anatomy of the Liver—As an Allograft
    A.J. Demetris, C.O.C. Bellamy, C.R. Gandhi, S. Prost, Y. Nakanuma, D.B. Stolz
    American Journal of Transplantation.2016; 16(6): 1653.     CrossRef
  • The lymphatic system: A new frontier in hepatology
    Yasuko Iwakiri
    Hepatology.2016; 64(3): 706.     CrossRef
  • Anatomy of hepatic lymphatics and its implications in hepatic malignancies
    Tuck Leong Yong, Nezor Houli, Chris Christophi
    ANZ Journal of Surgery.2016; 86(11): 868.     CrossRef
  • The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis
    Masatake Tanaka, Yasuko Iwakiri
    Cellular and Molecular Gastroenterology and Hepatology.2016; 2(6): 733.     CrossRef
  • Importance Rat Liver Morphology and Vasculature in Surgical Research
    Katarína Vdoviaková, Katarína Vdoviaková, Eva Petrovová, Lenka Krešáková, Marcela Maloveská, Jana Teleky, Janka Jenčová, Jozef Živčák, Andrej Jenča Jr.
    Medical Science Monitor.2016; 22: 4716.     CrossRef
  • Avicenna (980-1037) on the Role of the Liver in Separating Fluid from the Blood, with Insight into the Process from E.H. Starling (1866-1907) a Millennium Later
    Leon G. Fine
    Nephron.2016; 133(2): 139.     CrossRef
  • The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics
    Yuji Morine, Mitsuo Shimada
    Journal of Gastroenterology.2015; 50(9): 913.     CrossRef
  • Nitric oxide in liver diseases
    Yasuko Iwakiri, Moon Young Kim
    Trends in Pharmacological Sciences.2015; 36(8): 524.     CrossRef
  • Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions
    Yasuko Iwakiri, Vijay Shah, Don C. Rockey
    Journal of Hepatology.2014; 61(4): 912.     CrossRef
  • Pathophysiology of Portal Hypertension
    Yasuko Iwakiri
    Clinics in Liver Disease.2014; 18(2): 281.     CrossRef
  • Formation of Fenestrae in Murine Liver Sinusoids Depends on Plasmalemma Vesicle-Associated Protein and Is Required for Lipoprotein Passage
    Leonie Herrnberger, Robert Hennig, Werner Kremer, Claus Hellerbrand, Achim Goepferich, Hans Robert Kalbitzer, Ernst R. Tamm, Rafael Aldabe
    PLoS ONE.2014; 9(12): e115005.     CrossRef
  • Effects of Adenosine on Lymphangiogenesis
    Bénédicte Lenoir, Daniel R. Wagner, Silvia Blacher, Graciela B. Sala-Newby, Andrew C. Newby, Agnès Noel, Yvan Devaux, Philippe Rouet
    PLoS ONE.2014; 9(3): e92715.     CrossRef
  • Update December 2013
    Francine Blei
    Lymphatic Research and Biology.2013; 11(4): 239.     CrossRef
  • 18,448 View
  • 258 Download
  • 78 Web of Science
  • Crossref

Original Article

Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines
Sung Hoon Choi, Hye Won Shin, Jun Yong Park, Ji Young Yoo, Do Young Kim, Weon Sang Ro, Chae-Ok Yun, Kwang-Hyub Han
Korean J Hepatol 2010;16(3):280-287.
Published online September 30, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.3.280
Background/Aims

Hypoxia-inducible factor-1α (HIF-1α) is a central transcriptional factor involved in the cellular responses related to various aspects of cancer biology, including proliferation, survival, and angiogenesis, and the metabolism of the extracellular matrix in hypoxia. This study evaluated whether adenovirus-mediated small hairpin RNA (shRNA) against HIF-1α (shHIF-1α) inhibits cell proliferation and angiogenesis in hepatocellular carcinoma (HCC) cell lines.

Methods

Knockdown of HIF-1α expression was constructed by adenovirus-mediated RNA interference tools, and HCC cell lines infected with shHIF-1α coding virus were cultured under a hypoxia condition (1% O2) for 24 hours. Following infection, the expression levels of HIF-1α, angiogenesis factors, and matrix metalloproteinase (MMP) were examined using Western blotting. Cell proliferation and angiogenesis were measured by a cell proliferation assay (MTT assay) and an angiogenesis-related assay (invasion and tube-formation assay), respectively.

Results

Adenovirus mediated inhibition of HIF-1α induced suppression of tumor growth in HCC cell lines. It also down-regulated the expression of angiogenesis factor and MMP proteins. Angiogenesis as well as mobility of vascular cells to tumor was suppressed by adenovirus-mediated shHIF-1α-infected groups in human umbilical vein endothelial cells (HUVECs).

Conclusions

These data suggest that adenovirus-mediated inhibition of HIF-1α inhibits the invasion, tube formation, and cell growth in HUVECs and HCC cells.

Citations

Citations to this article as recorded by  Crossref logo
  • Therapeutic Synergy of Silibinin‐Loaded Nanogel and Low‐Dose Gamma Radiation in Hepatocellular Carcinoma: Emphasis on EMT, Angiogenesis, and Immune Response
    Zakaria Mohamed Alghzzawy, Mohammed Hussein Awwad, Tarek Khaled Elmaghraby, Sanaa Abd El‐Hamid Hagag, Azza Elsayed Kayed, Doaa Sabry Ibrahim
    Advanced Therapeutics.2025;[Epub]     CrossRef
  • RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity
    Sun-Mi Yoo, Cheol-Jung Lee, Hyun-Jung An, Joo Young Lee, Hye Suk Lee, Han Chang Kang, Sung-Jun Cho, Seung-Min Kim, Juhee Park, Dae Joon Kim, Yong-Yeon Cho
    International Journal of Molecular Sciences.2019; 20(8): 1994.     CrossRef
  • Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma
    D Shneor, R Folberg, J Pe'er, A Honigman, S Frenkel
    Cancer Gene Therapy.2017; 24(2): 64.     CrossRef
  • Tumor angiogenesis and vascular normalization: alternative therapeutic targets
    Claire Viallard, Bruno Larrivée
    Angiogenesis.2017; 20(4): 409.     CrossRef
  • ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α
    Joon Ho Lee, Wonhee Hur, Sung Woo Hong, Jung-Hee Kim, Sung Min Kim, Eun Byul Lee, Seung Kew Yoon
    Oncology Reports.2017; 37(2): 813.     CrossRef
  • RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells
    ChengShi Chen, Rong Liu, JianHua Wang, ZhiPing Yan, Sheng Qian, Wei Zhang
    Cell Biochemistry and Biophysics.2015; 71(3): 1677.     CrossRef
  • Inhibition of tumour angiogenesis and growth by small hairpin HIF‐1α and IL‐8 in hepatocellular carcinoma
    Sung Hoon Choi, Oh‐Joon Kwon, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Simon Weonsang Ro, Kyung Sik Kim, Jeon Han Park, Seungtaek Kim, Chae‐Ok Yun, Kwang‐Hyub Han
    Liver International.2014; 34(4): 632.     CrossRef
  • The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
    Dongjun Luo, Zhongxia Wang, Junyi Wu, Chunping Jiang, Junhua Wu
    BioMed Research International.2014; 2014: 1.     CrossRef
  • Expression and significance of MMP2 and HIF-1α in hepatocellular carcinoma
    BIN WANG, YOU-MING DING, PING FAN, BING WANG, JUN-HUI XU, WEI-XING WANG
    Oncology Letters.2014; 8(2): 539.     CrossRef
  • Signaling pathways bridging microbial-triggered inflammation and cancer
    Maulilio John Kipanyula, Paul Faustin Seke Etet, Lorella Vecchio, Mohammed Farahna, Elias Nchiwan Nukenine, Armel Hervé Nwabo Kamdje
    Cellular Signalling.2013; 25(2): 403.     CrossRef
  • The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma
    Shi-Yun Cui, Jia-Yuan Huang, Yi-Tian Chen, Hai-Zhu Song, Gui-Chun Huang, Wei De, Rui Wang, Long-Bang Chen
    Cell Cycle.2013; 12(17): 2849.     CrossRef
  • Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
    Jin-Wook Kim
    The Korean Journal of Hepatology.2010; 16(3): 278.     CrossRef
  • 12,791 View
  • 68 Download
  • Crossref

Editorial

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
Jin-Wook Kim
Korean J Hepatol 2010;16(3):278-279.
Published online September 30, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.3.278

Citations

Citations to this article as recorded by  Crossref logo
  • Effect and Molecular Mechanisms of Jiedu Recipe on Hypoxia-Induced Angiogenesis after Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
    Wanfu Lin, Huan Wang, Maofeng Zhong, Shasha Yu, Shasha Zhao, Shufang Liang, Juan Du, Binbin Cheng, Wei Gu, Changquan Ling, Muhammad Nabeel Ghayur
    Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
  • Hypoxia-inducible factors as molecular targets for liver diseases
    Cynthia Ju, Sean P. Colgan, Holger K. Eltzschig
    Journal of Molecular Medicine.2016; 94(6): 613.     CrossRef
  • The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
    Dongjun Luo, Zhongxia Wang, Junyi Wu, Chunping Jiang, Junhua Wu
    BioMed Research International.2014; 2014: 1.     CrossRef
  • 9,386 View
  • 35 Download
  • Crossref

Original Article

Expression of Caveolin in Hepatocellular Carcinoma: Association with Unpaired Artery Formation and Radiologic Findings
Ha Na Choi, M.S., Kyung Ryoul Kim, Ph.D., Ho Sung Park, M.D., Kyu Yun Jang, M.D., Myoung Jae Kang, M.D., Dong Geun Lee, M.D., Young Kon Kim, M.D.1, Baik Hwan Cho, M.D.2, Eun Jung Cha, M.D., Woo Sung Moon, M.D.
Korean J Hepatol 2007;13(3):396-408.
Published online September 20, 2007
DOI: https://doi.org/10.3350/kjhep.2007.13.3.396
Background/Aims
Hepatocellular carcinoma (HCC) is becoming one of the common malignant tumors worldwide, and it is characterized by its high vascularity. Caveolin is the major structural protein in caveolae, which are small omega-shaped invaginations within the plasma membrane. Caveolin has been implicated in mitogenic signaling, oncogenesis and angiogenesis. The expression of caveolin-1 and -2 in HCC and its potential relationship with angiogenesis has not been examined. Methods: Paraffin sections of 35 HCC specimens were immunostained with caveolin-1, caveolin-2, alpha-smooth muscle actin, and CD34 antibodies. In addition, the expression of caveolin-1 and -2 mRNA in HCC was examined. The relationship between the radiological findings and the number of unpaired arteries and microvessel density (MVD) was also investigated. Results: Caveolin-1 and -2 were expressed in the sinusoidal endothelial cells in 20 out of 35, and 18 out of 35 HCC specimens, respectively. Caveolin-1 and -2 were also expressed in the smooth muscle cells of the unpaired arteries in 26 out of 35, and 18 out of 35 HCC specimens, respectively. Increased expression of caveolin-1 and -2 mRNA was detected in 26.7% and 33.3% of the tumor specimens, respectively, compared with the corresponding non-tumorous adjacent liver tissues. There was a significant correlation between expression of caveolin-1, -2 in the smooth muscle cells of unpaired arteries and the number of unpaired arteries. The number of unpaired arteries in HCCs was found to be associated with the degree of contrast enhancement in the arterial phase imaging. However, it did not correlate with the degree of MVD. Conclusions: These findings suggest that the expression of caveolin-1, -2 is associated with the formation of unpaired arteries in HCC. In addition, there is a correlation between the degree of contrast enhancement of the HCC in the arterial phase image and the number of unpaired arteries. (Korean J Hepatol 2007;13:396- 408)

Citations

Citations to this article as recorded by  Crossref logo
  • Caveolin-1 Knockdown Decreases SMMC7721 Human Hepatocellular Carcinoma Cell Invasiveness by Inhibiting Vascular Endothelial Growth Factor-Induced Angiogenesis
    Zhi-Bo Zhang, Zheng Shi, Lan-Fang Yang, Hong-Bin Gao
    Canadian Journal of Gastroenterology and Hepatology.2020; 2020: 1.     CrossRef
  • Nitric oxide-matrix metaloproteinase-9 interactions: Biological and pharmacological significance
    Shane O'Sullivan, Carlos Medina, Mark Ledwidge, Marek W. Radomski, John F. Gilmer
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2014; 1843(3): 603.     CrossRef
  • Caveolin and cavin family members: Dual roles in cancer
    Reshu Gupta, Chirine Toufaily, Borhane Annabi
    Biochimie.2014; 107: 188.     CrossRef
  • CAV1 Promotes HCC Cell Progression and Metastasis through Wnt/β-Catenin Pathway
    Hongxiu Yu, Huali Shen, Yang Zhang, Fan Zhong, Yinkun Liu, Lunxiu Qin, Pengyuan Yang, Yick-Pang Ching
    PLoS ONE.2014; 9(9): e106451.     CrossRef
  • Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer
    Yu Tang, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi
    Medical Oncology.2012; 29(2): 977.     CrossRef
  • Overexpression of Caveolin-1 in Hepatocellular Carcinoma with Metastasis and Worse Prognosis: Correlation with Vascular Endothelial Growth Factor, Microvessel Density and Unpaired Artery
    Zhi-Bo Zhang, Lei Cai, Shu-Guo Zheng, Yan Xiong, Jia-Hong Dong
    Pathology & Oncology Research.2009; 15(3): 495.     CrossRef
  • Caveats of caveolin-1 in cancer progression
    Elke Burgermeister, Mordechai Liscovitch, Christoph Röcken, Roland M. Schmid, Matthias P.A. Ebert
    Cancer Letters.2008; 268(2): 187.     CrossRef
  • 7,987 View
  • 32 Download
  • Crossref

Review

The Role of Activated Hepatic Stellate Cells in Liver Fibrosis, Portal Hypertension and Cancer Angiogenesis
June Sung Lee , Jong Hoon Kim
Korean J Hepatol 2007;13(3):309-319.
Published online September 20, 2007
DOI: https://doi.org/10.3350/kjhep.2007.13.3.309
Although hepatic stellate cells, which are liver specific pericytes, have been recognized within the vasculature of the sinusoid for more than one hundred years, the biology and function of these cells is unclear. Recent studies have highlighted the key role of stellate cells in a number of fundamental processes that include wound healing/fibrosis, vasoregulation, and vascular remodeling/angiogenesis. In the liver, these processes are particularly important in the development of cirrhosis, portal hypertension and cancer. This article highlights the recent advances in our understanding of the biology of hepatic stellate cells and discusses some of the recently-ascribed functions that are relevant to liver fibrosis, portal hypertension and cancer angiogenesis. (Korean J Hepatol 2007;13:309-319)

Citations

Citations to this article as recorded by  Crossref logo
  • Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling
    Mar Coll, Silvia Ariño, Celia Martínez‐Sánchez, Ester Garcia‐Pras, Javier Gallego, Anna Moles, Beatriz Aguilar‐Bravo, Delia Blaya, Julia Vallverdú, Teresa Rubio‐Tomás, Juan Jose Lozano, Elisa Pose, Isabel Graupera, Andrea Fernández‐Vidal, Albert Pol, Ramó
    Hepatology.2022; 75(2): 353.     CrossRef
  • Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive
    Bing Han, Huan Tang, Qiming Liang, Ming Zhu, Yizhuo Xie, Jinglin Chen, Qianwen Li, Juan Jia, Yan Li, Zhihui Ren, Dengli Cong, Xiaofeng Yu, Dayun Sui, Jin Pei
    Drug Delivery.2021; 28(1): 719.     CrossRef
  • New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials
    Kai Qu, Zichao Huang, Ting Lin, Sinan Liu, Hulin Chang, Zhaoyong Yan, Hongxin Zhang, Chang Liu
    Frontiers in Pharmacology.2016;[Epub]     CrossRef
  • Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?
    Kai Qu, Tian Liu, Ting Lin, Xing Zhang, Ruixia Cui, Sinan Liu, Fandi Meng, Jingyao Zhang, Minghui Tai, Yong Wan, Chang Liu
    Oncotarget.2016; 7(41): 67650.     CrossRef
  • The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells
    Yang Bu, Qing-An Jia, Zheng-Gang Ren, Tong-Chun Xue, Quan-Bao Zhang, Ke-Zhi Zhang, Qiang-Bo Zhang, Yang You, Hui Tian, Lun-Xiu Qin, Zhao-You Tang
    Oncotarget.2015; 6(37): 40068.     CrossRef
  • Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?
    Can-Jie Guo, Qin Pan, Hua Xiong, Yu-Qi Qiao, Zhao-Lian Bian, Wei Zhong, Li Sheng, Hai Li, Lei Shen, Jing Hua, Xiong Ma
    BioMed Research International.2014; 2014: 1.     CrossRef
  • MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases
    Yong He, Cheng Huang, Xiang Lin, Jun Li
    Biochimie.2013; 95(7): 1355.     CrossRef
  • Anti-fibrotic Effect of Mori Folium Extract in Hepatic Stellate Cells
    Sung Hui Byun, Sang Mi Park, Sang Chan Kim, Il Je Cho
    The Korea Journal of Herbology.2013; 28(4): 49.     CrossRef
  • Herbal compound “Songyou Yin” attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells
    Qing-An Jia, Zhi-Ming Wang, Zheng-Gang Ren, Yang Bu, Xiao-Ying Xie, Yan-Hong Wang, Lan Zhang, Qiang-Bo Zhang, Tong-Chun Xue, Li-Fen Deng, Zhao-You Tang
    BMC Complementary and Alternative Medicine.2013;[Epub]     CrossRef
  • Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension
    Ali Amin, Soo-Kyoung Choi, Yehia Osman-Elazeik, Nariman K. Badr El-Din, Christopher G. Kevil, Louis G. Navar, Philip Kadowitz, Mohamed Trebak, Khalid Matrougui
    Pflügers Archiv - European Journal of Physiology.2012; 464(6): 583.     CrossRef
  • Treatment Update on Portal Hypertension and Complications
    Jin Woo Lee
    The Korean Journal of Gastroenterology.2010; 56(3): 144.     CrossRef
  • Current status of liver diseases in Korea: Liver cirrhosis
    Jeong Won Jang
    The Korean Journal of Hepatology.2009; 15(Suppl 6): S40.     CrossRef
  • 7,450 View
  • 61 Download
  • Crossref

Editorial

Role of Angiogenic Factors during the Hepatocarcinogenesis
Young Nyun Park
Korean J Hepatol 2001;7(1):12-14.
  • 3,741 View
  • 18 Download

Original Article

Implications of Serum Levels of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Chronic Liver Diseases and Hepatocellular Carcinoma
Sung Jae Yoo, M.D, Sung Moon Jung, M.D, Jong Gwang Kim, M.D, Jin Ok Lee, M.D, Yong Whan Song, M.D, Chul Ju Han, M.D, Sook-Hyang Jung, M.D, You Cheoul Kim, M.D, Chang-Min Kim, M.D, Jhin Oh Lee, M.D, Young Joon Hong, M.D* and Seok Il Hong, M.D*
Korean J Hepatol 2001;7(1):47-54.
Background/Aims
Angiogenesis occurs in response to tissue damage, and is of vital importance for tumor growth and metastasis. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are potent angiogenic factors, and have been suggested to be useful diagnostic markers in certain hypervascular tumors. However, little is known of serum bFGF and VEGF in patients with hepatocellular carcinoma (HCC). We attempted to measure serum bFGF and VEGF in patients with chronic liver diseases (CLD) and HCC to assess their pathogenetic role and usability as tumor markers. Methods: Serum bFGF and VEGF were measured in 8 patients with chronic hepatitis (CH), 15 patients with liver cirrhosis (LC), and 49 patients with HCC. bFGF was measured in 33, and VEGF was measured in 50, healthy blood donors. Results: Serum bFGF was 3.8±1.9, 2.0±1.4, 4.2±6.0, 17.4±30.0 pg/mL in normal control, CH, LC, HCC, respectively. The serum bFGF level was significantly increased in patients with HCC when compared with normal control or patients with CLD. No difference, however, was observed in serum VEGF levels among the four groups. The serum levels of bFGF and VEGF were not significantly different in patients with HCC according to tumor type, size and stage. Serum bFGF showed good sensitivity (90%), specificity (87%), and positive predictive value (94%) in differentiating patients with HCC from those with CLD at the cut-off value of 4.6 pg/mL. Conclusions: bFGF might play a role in the growth of HCC and its serum level might be used as a tumor marker. On the other hand, serum VEGF does not seem to be an adequate tumor marker.(Korean J Hepatol 2001;7:47-54)
  • 3,431 View
  • 21 Download

Review

Hypoxia in Hepatocellular Carcinoma
Sun Jung Myung , Jung Hwan Yoon
Korean J Hepatol 2007;13(1):9-19.
Hepatocellular carcinoma (HCC) is characterized by hypervascularity, indicating that angiogenesis plays a vital role in HCC growth and progression. A number of anti-angiogenic therapies are being utilized in clinical trials in patients with HCC. However, the therapeutic efficacy of anti-angiogenic monotherapy is still insufficient. While inhibition of angiogenesis results in tumor hypoxia and cell death, this inhibition may also activate hypoxia-induced cell signals that may promote HCC progression. Therefore, an understanding of these signals may be essential in designing efficient anti-angiogenic therapies. This review summarizes the role of hypoxia-induced signals in HCC. (Korean J Hepatol 2007;13:9-19)
  • 4,241 View
  • 25 Download

Original Article

The Role of Angiostatin, Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9 and 12 in the Angiogenesis of Hepatocellular Carcinoma
Sook Kim, M.D.1, Ho Sung Park, M.D., Hyun Jin Son, M.D. and Woo Sung Moon, M.D.
Korean J Hepatol 2004;10(1):62-72.
Background/Aims
Tumor angiogenesis, a major requirement for tumor growth and metastasis, is regulated by pro- and anti-angiogenic factors. Hepatocellular carcinoma (HCC) has become a common malignant tumor worldwide. It is characterized by a high vascularity. Methods: We studied the immunohistochemical expression of angiostatin, vascular endothelial cell growth factor (VEGF), matrix metalloproteinase (MMP)-9 and MMP-12, and the relationship between these results and the microvessel density (MVD) in 48 HCC specimens. To determine whether HCC cells express angiostatin per se, we examined the expression of angiostatin, MMP-9 and MMP-12 by Western blotting in four HCC cell lines.
Results
Expression of angiostatin and MMP-12 (but not MMP-9) were strongly correlated with decreased MVD in HCCs (P=0.006, P=0.038, respectively). VEGF positive tumors showed a significantly higher MVD than VEGF negative tumors (P=0.01). We divided the 48 cases into the following four groups: group A, angiostatin (+), MMP-9 or -12 (+), and VEGF (-); group B, angiostatin (-) and VEGF (-); group C, angiostatin (+), MMP-9 or -12 (+), and VEGF (+); group D, angiostatin (-) and VEGF (+). There was a significant correlation with MVD among these groups (P<0.001). Angiostatin was detected by Western blotting in 2 out of 4 HCC cell lines and was associated with plasminogen and MMP expression.
Conclusions
These results indicate that angiogenesis in HCC is a complex process involving multiple factors including angiostatin, VEGF, and MMP. Our results suggest that angiostatin is generated by MMP-mediated proteolysis of plasminogen in HCC cells.(Korean J Hepatol 2004;10:62-72)
  • 4,031 View
  • 25 Download
Hepatology Elsewhere
Topics Related to Hepatocellular Carcinoma
Il Han Song
Korean J Hepatol 2004;10(2):174-176.
  • 3,437 View
  • 14 Download